课题基金 / 基金详情

ANTHRACYCLINE CARDIOTOXICITY--OXIDATIVE STRESS

ANTHRACYCLINE CARDIOTOXICITY--OXIDATIVE STRESS
蒽环类药物心脏毒性——氧化应激
批准号:
6537561
负责人:
NARINE SARVAZYAN
金额:
$17.14万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2004-03-31

项目摘要

项目成果

NARINE SARVAZYAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Doxorubicin and its derivatives are among the most potent anticancer drugs known. Unfortunately their therapeutic efficacy is severely restricted by a dose-accumulated cardiotoxicity. Our preliminary results using adult rat cardiomyocytes as a working model, have shown evidence for the mechanism which could explain how reactive oxygen species generated by doxorubicin provoke myofibrillar degeneration while not causing severe oxidative damage. Specifically, 1) we visualized directly doxorubicin accumulation in cardiac mitochondria and subsequent increase in intracellular oxidation in living cardiomyocytes, 2) observed that doxorubicin administration is associated with redistribution of the protein kinase C epsilon isoform from cytosol to myofibrils, and 3) detected disruption of the periodicity of actin staining after repetitive exposure of myocytes to clinically relevant drug concentrations. Based on these data we propose the following sequence of events: doxorubicin rapidly accumulates in cardiac mitochondria; it then initiates lipid peroxidation via formation of superoxide and drug complexes with transition metals; and although the degree of lipid peroxidation is small and no significant membrane damage occurs, it leads to the activation of phospholipases; lipase thereupon release several second messengers, including arachidonic acid, activating a specific protein kinase C isoform; the kinase then initiates myofibrillar degeneration. To support the above hypothesis we aim to 1) establish a causal relationship between observed doxorubicin-induced kinase translocation and increased free radical formation; 2) to determine whether doxorubicin-induced free radicals and/or protein kinase C translocation are prerequisites for changes in myocyte myofibrillar organization and cell contractility; 3) to uncover role of phospholipase A2 in doxorubicin-induced activation of kinase and ensuing changes in myofibrillar organization and contractility. The proposed experiments aim to reveal explicit pathways through which reactive oxygen species are involved in anthracycline- induced cardiomyopathy. The studies will also provide new information about kinases involvement in myofilament degeneration and interaction between reactive oxygen species and signal transduction pathways.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
膜相关的非钙依赖性磷脂酶 A2 的抑制是蒽环类药物心脏毒性的潜在罪魁祸首。
DOI: --
发表时间: 2003
期刊: Cancer research
影响因子: 11.2
作者: [Swift,Luther, McHowat,Jane, Sarvazyan,Narine]
通讯作者: Sarvazyan,Narine
Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress.
二氯荧光素在心肌细胞中的定位:对氧化应激评估的影响。
DOI: 10.1152/ajpheart.2000.278.3.h982
发表时间: 2000
期刊: American journal of physiology. Heart and circulatory physiology
影响因子: --
作者: [Swift,LM, Sarvazyan,N]
通讯作者: Sarvazyan,N
DOI: 10.1200/jco.2007.14.9401
发表时间: 2008-08-01
期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子: --
作者: [Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB]
通讯作者: Sawyer DB
Changes in phospholipid content and myocardial calcium-independent phospholipase A2 activity during chronic anthracycline administration.
慢性蒽环类药物给药期间磷脂含量和心肌钙非依赖性磷脂酶 A2 活性的变化。
DOI: 10.1124/jpet.104.069419
发表时间: 2004
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [McHowat,Jane, Swift,LutherM, Crown,KimberlyN, Sarvazyan,NarineA]
通讯作者: Sarvazyan,NarineA
8
    New generation of catheters for treatment of atrial fibrillation
    Cardiomyocyte-derived Venous Assist Device: Aiding peripheral blood flow
    • 批准号:
      8968858
    • 项目类别:
    • 资助金额:
      $19.81万
    • 财政年份:
      2014
    • 负责人:
      NARINE SARVAZYAN
    • 依托单位:
    New generation of catheters for treatment of atrial fibrillation
    Cardiomyocyte-derived Venous Assist Device: Aiding peripheral blood flow
    • 批准号:
      8824058
    • 项目类别:
    • 资助金额:
      $23.38万
    • 财政年份:
      2014
    • 负责人:
      NARINE SARVAZYAN
    • 依托单位:
    海外基金